Enrichment-based DNA methylation analysis using next-generation sequencing: sample exclusion, estimating changes in global methylation, and the contribution of replicate lanes

التفاصيل البيبلوغرافية
العنوان: Enrichment-based DNA methylation analysis using next-generation sequencing: sample exclusion, estimating changes in global methylation, and the contribution of replicate lanes
المؤلفون: Michael P. Trimarchi, Ralf Bundschuh, John Curfman, Mark Murphy, Guido Marcucci, Pearlly S. Yan, Benjamin Rodriguez, David Frankhouser
المصدر: BMC Genomics
سنة النشر: 2013
مصطلحات موضوعية: Quality Control, Biology, Proteomics, DNA sequencing, 03 medical and health sciences, 0302 clinical medicine, Genetics, Humans, Epigenetics, Biomarker discovery, Promoter Regions, Genetic, 030304 developmental biology, Ovarian Neoplasms, 0303 health sciences, Research, High-Throughput Nucleotide Sequencing, Methylation, DNA, DNA Methylation, 3. Good health, Endometrial Neoplasms, Leukemia, Myeloid, Acute, DNA methylation, Illumina Methylation Assay, CpG Islands, Female, DNA microarray, 030217 neurology & neurosurgery, Biotechnology
الوصف: Background DNA methylation is an important epigenetic mark and dysregulation of DNA methylation is associated with many diseases including cancer. Advances in next-generation sequencing now allow unbiased methylome profiling of entire patient cohorts, greatly facilitating biomarker discovery and presenting new opportunities to understand the biological mechanisms by which changes in methylation contribute to disease. Enrichment-based sequencing assays such as MethylCap-seq are a cost effective solution for genome-wide determination of methylation status, but the technical reliability of methylation reconstruction from raw sequencing data has not been well characterized. Methods We analyze three MethylCap-seq data sets and perform two different analyses to assess data quality. First, we investigate how data quality is affected by excluding samples that do not meet quality control cutoff requirements. Second, we consider the effect of additional reads on enrichment score, saturation, and coverage. Lastly, we verify a method for the determination of the global amount of methylation from MethylCap-seq data by comparing to a spiked-in control DNA of known methylation status. Results We show that rejection of samples based on our quality control parameters leads to a significant improvement of methylation calling. Additional reads beyond ~13 million unique aligned reads improved coverage, modestly improved saturation, and did not impact enrichment score. Lastly, we find that a global methylation indicator calculated from MethylCap-seq data correlates well with the global methylation level of a sample as obtained from a spike-in DNA of known methylation level. Conclusions We show that with appropriate quality control MethylCap-seq is a reliable tool, suitable for cohorts of hundreds of patients, that provides reproducible methylation information on a feature by feature basis as well as information about the global level of methylation.
تدمد: 1471-2164
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2371158547f9621268793d2c361a9fTest
https://pubmed.ncbi.nlm.nih.gov/23281662Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....0f2371158547f9621268793d2c361a9f
قاعدة البيانات: OpenAIRE